Por favor, use este identificador para citar o enlazar este ítem:
https://repositorio.uca.edu.ar/handle/123456789/13680
Campo DC | Valor | Lengua/Idioma |
---|---|---|
dc.contributor.author | Pandi Perumal, Seithikurippu R. | es |
dc.contributor.author | Cardinali, Daniel Pedro | es |
dc.contributor.author | Reiter, R. | es |
dc.contributor.author | Brown, Gregory M. | es |
dc.date.accessioned | 2022-03-25T11:37:51Z | - |
dc.date.available | 2022-03-25T11:37:51Z | - |
dc.date.issued | 2020 | - |
dc.identifier.citation | Pandi Perumal, S. R. et al. Low melatonin as a contributor to SARS-CoV-2 disease [en línea]. Melatonin Research. 2020, 3 (4). doi: 10.32794/mr11250079. Disponible en: https://repositorio.uca.edu.ar/handle/123456789/13680 | es |
dc.identifier.uri | https://repositorio.uca.edu.ar/handle/123456789/13680 | - |
dc.description.abstract | Abstract: That the pineal gland is a source of melatonin is widely known; however, by comparison, few know of the much larger pool of extrapineal melatonin. That pool is widely distributed in all animals, including those that do not have a pineal gland, e.g., insects. Extrapineal melatonin is not released into the blood but is used locally to function as an antioxidant, anti-inflammatory agent, etc. A major site of action of peripherally-produced melatonin is the mitochondria where it neutralizes reactive oxygen species (ROS) that are generated during oxidative phosphorylation. Its role also includes major actions as an immune modulator reducing overreactions to foreign agents while simultaneously boosting immune processes. During a pandemic such as coronavirus disease 2019 (COVID-19), caused by the virus SARS-CoV-2, melatonin is capable of suppressing the damage inflicted by the cytokine storm. The implications of melatonin in susceptibility and treatment of COVID-19 disease are discussed. | es |
dc.format | application/pdf | es |
dc.language.iso | eng | es |
dc.rights | Acceso abierto | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-sa/4.0/ | * |
dc.source | Melatonin Research. 2020, 3 (4) | es |
dc.subject | COVID-19 | es |
dc.subject | SARS-CoV-2 | es |
dc.subject | CORONAVIRUS | es |
dc.subject | MELATONINA | es |
dc.subject | MITOCONDRIAS | es |
dc.subject | CITOQUINAS | es |
dc.title | Low melatonin as a contributor to SARS-CoV-2 disease | es |
dc.type | Artículo | es |
dc.identifier.doi | 10.32794/mr11250079 | - |
uca.disciplina | MEDICINA | es |
uca.issnrd | 1 | es |
uca.affiliation | Fil: Pandi Perumal, Seithikurippu R. Somnogen Canada Inc; Canadá | es |
uca.affiliation | Fil: Cardinali, Daniel Pedro. Pontificia Universidad Católica Argentina. Facultad de Ciencias Médicas; Argentina | es |
uca.affiliation | Fil: Reiter, R. UT Health San Antonio. Department of Cell Systems and Anatomy; Estados Unidos | es |
uca.affiliation | Fil: Brown, Gregory M. Univeridad de Toronto. Centro para la Adicción y la Salud Mental. Ciencias Moleculares del Cerebro; Canadá | es |
uca.version | publishedVersion | es |
item.grantfulltext | open | - |
item.fulltext | With Fulltext | - |
item.languageiso639-1 | en | - |
crisitem.author.dept | Consejo Nacional de Investigaciones Científicas y Técnicas | - |
crisitem.author.dept | Instituto de Investigaciones Biomédicas - BIOMED | - |
crisitem.author.dept | Facultad de Ciencias Médicas | - |
crisitem.author.orcid | 0000-0002-0813-9088 | - |
crisitem.author.parentorg | Facultad de Ciencias Médicas | - |
crisitem.author.parentorg | Pontificia Universidad Católica Argentina | - |
Aparece en las colecciones: | Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
low-melatonin-contributor.pdf | 308,45 kB | Adobe PDF | Visualizar/Abrir |
Visualizaciones de página(s)
143
comprobado en 25-abr-2024
Descarga(s)
91
comprobado en 25-abr-2024
Google ScholarTM
Consultar
Altmetric
Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons